CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Price, Forecast & Analysis
Canada • TSX Venture Exchange • TSX-V:CYTO • CA2328211081
CYTO.CA Key Statistics, Chart & Performance
The current stock price of CYTO.CA is 0.145 CAD. In the past month the price decreased by -3.33%. In the past year, price decreased by -39.58%.
CYTO.CA Technical Analysis
CYTO.CA Financial Highlights
Over the last trailing twelve months CYTO.CA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 71.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -143.59% | ||
| ROE | -391.47% | ||
| Debt/Equity | 0.98 |
CYTO.CA Forecast & Estimates
CYTO.CA Ownership
About CYTO.CA
Company Profile
Cytophage Technologies Ltd. is a pioneering biotechnology company, which engages in bacteriophage research, product development, and commercialization. The company is headquartered in Oak Bluff, Manitoba. The company went IPO on 2022-02-01. The Company’s business activity is to develop bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and treatment. Bacteriophages are viruses that only infect and kill bacteria. These natural killers of bacteria can overcome cellular or organism-level defenses. The firm is using de-risked and patented technology to advance products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is a poultry health product offered by the Company.
Company Info
CYTOPHAGE TECHNOLOGIES LTD
200A-400 Fort Whyte Way
Oak Bluff MANITOBA CA
Employees: 0
Phone: 14162144810
CYTOPHAGE TECHNOLOGIES LTD / CYTO.CA FAQ
What does CYTO do?
Cytophage Technologies Ltd. is a pioneering biotechnology company, which engages in bacteriophage research, product development, and commercialization. The company is headquartered in Oak Bluff, Manitoba. The company went IPO on 2022-02-01. The Company’s business activity is to develop bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and treatment. Bacteriophages are viruses that only infect and kill bacteria. These natural killers of bacteria can overcome cellular or organism-level defenses. The firm is using de-risked and patented technology to advance products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is a poultry health product offered by the Company.
Can you provide the latest stock price for CYTOPHAGE TECHNOLOGIES LTD?
The current stock price of CYTO.CA is 0.145 CAD. The price decreased by -9.38% in the last trading session.
Does CYTO stock pay dividends?
CYTO.CA does not pay a dividend.
How is the ChartMill rating for CYTOPHAGE TECHNOLOGIES LTD?
CYTO.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.